Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease L Zhang, V Rajan, E Lin, Z Hu, HQ Han, X Zhou, Y Song, H Min, X Wang, ... The FASEB journal 25 (5), 1653, 2011 | 329 | 2011 |
Oncolytic viral therapies E Lin, J Nemunaitis Cancer gene therapy 11 (10), 643-664, 2004 | 171 | 2004 |
Overtreatment of enterococcal bacteriuria E Lin, Y Bhusal, D Horwitz, SA Shelburne, BW Trautner Archives of internal medicine 172 (1), 33-38, 2012 | 98 | 2012 |
Early rehospitalization after kidney transplantation: assessing preventability and prognosis M Harhay, E Lin, A Pai, MO Harhay, A Huverserian, A Mussell, P Abt, ... American Journal of Transplantation 13 (12), 3164-3172, 2013 | 95 | 2013 |
Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study E Lin, GM Chertow, B Yan, E Malcolm, JD Goldhaber-Fiebert PLoS medicine 15 (3), e1002532, 2018 | 57 | 2018 |
Home dialysis in the prospective payment system era E Lin, XS Cheng, KK Chin, T Zubair, GM Chertow, E Bendavid, ... Journal of the American Society of Nephrology 28 (10), 2993-3004, 2017 | 54 | 2017 |
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions D Geetha, A Kronbichler, M Rutter, D Bajpai, S Menez, A Weissenbacher, ... Nature Reviews Nephrology 18 (11), 724-737, 2022 | 50 | 2022 |
Hospitalizations among adults with chronic kidney disease in the United States: a cohort study SJ Schrauben, HY Chen, E Lin, C Jepson, W Yang, JJ Scialla, MJ Fischer, ... PLoS medicine 17 (12), e1003470, 2020 | 47 | 2020 |
Palliative care disincentives in CKD: changing policy to improve CKD care MK Tamura, AM O’Hare, E Lin, LM Holdsworth, E Malcolm, AH Moss American Journal of Kidney Diseases 71 (6), 866-873, 2018 | 36 | 2018 |
Policy and pandemic: the changing practice of nephrology during the coronavirus disease-2019 outbreak T Truong, M Dittmar, A Ghaffari, E Lin Advances in chronic kidney disease 27 (5), 390-396, 2020 | 27 | 2020 |
Evaluating the functionality of the symmetry ETG and Medstat MEG software in forming episodes of care using medicare data T MaCurdy, J Kerwin, J Gibbs, E Lin, C Cotterman, M O’Brien-Strain, ... Burlingame, CA: Accumen, LLC, 2008 | 26 | 2008 |
Payment for dialysis services in the individual market E Trish, M Fiedler, N Ning, L Gascue, L Adler, E Lin JAMA Internal Medicine 181 (5), 698-699, 2021 | 20 | 2021 |
The “advancing American kidney health” executive order: challenges and opportunities for the large dialysis organizations E Lin, PB Ginsburg, GM Chertow, JS Berns American Journal of Kidney Diseases 76 (5), 731-734, 2020 | 17 | 2020 |
Bacteria in the treatment of cancer. J Lin, E Lin, J Nemunaitis Current Opinion in Molecular Therapeutics 6 (6), 629-639, 2004 | 17 | 2004 |
Association between preoperative hemodialysis timing and postoperative mortality in patients with end-stage kidney disease V Fielding-Singh, MW Vanneman, T Grogan, JP Neelankavil, ... JAMA 328 (18), 1837-1848, 2022 | 16 | 2022 |
Health insurance in the first 3 months of hemodialysis and early vascular access E Lin, MW Mell, WC Winkelmayer, KF Erickson Clinical Journal of the American Society of Nephrology 13 (12), 1866-1875, 2018 | 16 | 2018 |
The Medicare access and CHIP reauthorization act: Implications for nephrology E Lin, T MaCurdy, J Bhattacharya Journal of the American Society of Nephrology 28 (9), 2590-2596, 2017 | 15 | 2017 |
Acral lentiginous melanoma—population, treatment, and survival using the NCDB from 2004 to 2015 SX Bian, L Hwang, J Hwang, O Ragab, GK In, D Peng, E Lin Pigment cell & melanoma research 34 (6), 1049-1061, 2021 | 14 | 2021 |
Competing with a pandemic: Trends in research design in a time of Covid-19 SX Bian, E Lin Plos one 15 (9), e0238831, 2020 | 14 | 2020 |
Prior hospitalization burden and the relatedness of 30-day readmissions in patients receiving hemodialysis E Lin, J Bhattacharya, GM Chertow Journal of the American Society of Nephrology 30 (2), 323-335, 2019 | 13 | 2019 |